Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:521 (28 February), doi:10.1136/bmj.328.7438.521-a
| The first 150 words of the full text of this article appear below. |
EDITORLaw argues that encouraging people to decide for themselves whether to attend for screening is ducking the issue.1 This is true only if a well founded public health programme for a specific disease has not been set up. Then, setting up a programme, as Law advocates, should be based on evidence, through rigorous scientific evaluation of efficacy through systematic review of high quality trials. Outcomes assessed should be both mortality and all associated adverse effects that affect an individual person's quality of life. Good quality evidence based information should also be made available to suit all citizens so that they have a better chance of arriving at an informed decision with their (equally well informed) health professional, if desired.
Provision of such evidence takes time. But the screening industry and the public are not prepared to wait: mammographic screening for those aged 40-50 is widely practised, yet the
-->
Hazel Thornton, honorary visiting fellow
Department of Health Sciences, University of Leicester "Saionara," Rowhedge, Colchester CO5 7EA hazelcagct@aol.com
Read all Rapid Responses